The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L.
Thrombosis and Haemostasis 68(1): 88
1992
ISSN/ISBN: 0340-6245 PMID: 1514180 Document Number: 395966
Document emailed within 1 workday
Related Documents
Chong, B.H.; Pitney, W.R.; Castaldi, P.A. 1982: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 2(8310): 1246-1249Izban, K.F.; Lietz, H.W.; Hoppensteadt, D.A.; Jeske, W.P.; Fareed, J.; Bakhos, M.; Walenga, J.M. 1999: Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia Seminars in Thrombosis and Hemostasis 25(Suppl 1): 51-56
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Kanno, M.; Edanaga, M.; Mizukami, N.; Tokinaga, Y.; Niiyama, Y.; Yamakage, M. 2015: Successful Management of Cardiopulmonary Bypass Using Heparin in a Patient with Previous History of Heparin-induced Thrombocytopenia Masui. Japanese Journal of Anesthesiology 64(4): 449-452
Laake, K.; Borchgrevink, C. 1977: Heparin hemorrhage and heparin-induced thrombocytopenia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 97(34-36): 1812
Oberst, M.; Vierling, P.; Thielemann, F. 1998: Heparin-associated thrombocytopenia (HAT) type II. An underestimated complication in prevention of thromboembolism with heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 69(2): 198-203
Greinacher, A.; Pötzsch, B.; Amiral, J.; Dummel, V.; Eichner, A.; Mueller-Eckhardt, C. 1994: Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thrombosis and Haemostasis 71(2): 247-251
Mak, K.H.; Kottke-Marchant, K.; Brooks, L.M.; Topol, E.J. 1998: In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia Thrombosis and Haemostasis 80(6): 989-993
Warkentin, T.E.; Hayward, C.P.; Smith, C.A.; Kelly, P.M.; Kelton, J.G. 1992: Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia Journal of Laboratory and Clinical Medicine 120(3): 371-379
Haas, S.; Walenga, J.M.; Jeske, W.P.; Fareed, J. 1999: Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications Seminars in Thrombosis and Hemostasis 25(Suppl 1): 67-75
Greinacher, A.; Michels, I.; Mueller-Eckhardt, C. 1992: Heparin-associated thrombocytopenia: the antibody is not heparin specific Thrombosis and Haemostasis 67(5): 545-549
Zhang, L.; Zhang, G. 1999: Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity Hunan Yi Ke da Xue Xue Bao 24(4): 309
Davies, J.A.; Menys, V.C. 1982: Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde Thrombosis Research 26(1): 31-41
Warkentin, T.E.; Heddle, N.M. 2003: Laboratory diagnosis of immune heparin-induced thrombocytopenia Current Hematology Reports 2(2): 148-157
Bicher, H.I. 1970: Anti-thrombotic effect of an heparin-like substance (SP 54) preventing red cell and platelet aggregation Arzneimittel-Forschung 20(3): 379-381
Bachelot-Loza, C.; Saffroy, R.; Lasne, D.; Chatellier, G.; Aiach, M.; Rendu, F. 1998: Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis Thrombosis and Haemostasis 79(3): 523-528
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Chigot, P.; De Gennes, C.; Samama, M.M. 1996: Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin Journal des Maladies Vasculaires 21(3): 121-125
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Kudriashov, B.A.; Liapina, L.A.; Molchanova, L.V.; Rustamova, B.A. 1970: Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin Voprosy Meditsinskoi Khimii 16(2): 161-168